There can often be many challenges to be faced when capturing and managing clinical trial data. Increasingly clinical…
International trade was never a simple business as it involves different countries, regulations, licenses and documentation requirements. Good control of documents is something which can always make the whole process smoother and reduce risks. For clinical trials, we import and export medication and different materials around the world which are accompanied by various documentation for smooth custom clearance. Two such documents are the Customs Invoice (CI) and Air Way Bill (AWB). When import or export license applications are submitted at various health agencies, these documents are often used as reference.
If the documents are incorrect, then the license application and the final IL/EL (import/export license) will also be incorrect.
Risks of incorrect documentation include:
Ultimately, in clinical research, these risks can jeopardize the delivery of clinical supplies to the trial subjects.
An accurate customs invoice should have following information to ensure a smooth international shipping process:
Where we can find common mistakes in the customs invoice?
While reviewing an Air Way Bill we should check the following details
Where we can find common mistakes in the Air Way Bill?
Foreign trade operations require a large amount of information and documents.
Before a study is submitted at the health agencies, it’s necessary to do a quality check of the materials list to be imported/exported, against the draft documents, such as the Customs Invoice and Air Way Bill.
Once the operation starts, it’s very important that new quality checks are performed for specific shipments. There will be a second review that all information matches between the final documents and to achieve the customs clearance processes.
With these two controls we will achieve successful delivery of the clinical material to the clinical trial sites and patients in a timely manner.
Adapting to personalized medicine and the host of changes it will bring is a necessity and an opportunity. To thrive in…
The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions The Connected Journey™ of…